Cravath Swaine & Moore represented Amgen. The Federal Trade Commission (“FTC”) filed suit in Illinois federal court in May 2023 seeking a temporary restraining order and a preliminary...
Federal Trade Commission v. Amgen Inc., et al.
Sanofi v. Amgen
df-mp Dörries Frank-Molnia & Pohlman and Bardehle Pagenberg advised Amgen, while Zwicker Schnappauf & Partne and Carpmaels & Ransford advised Sanofi. As part of their global...
Amgen’s $24 Billion Senior Notes Offering
Latham & Watkins advised Amgen, and Shearman & Sterling advised the underwriters. Amgen Inc. priced an offering of $24.0 billion aggregate principal amount of senior notes,...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Amgen’s $3 Billion Senior Unsecured Notes Offerings
Latham & Watkins represented Amgen in the offerings, while Shearman & Sterling represented represented the underwriters. Amgen Inc. executed a senior unsecured notes offerings consisting of US$1,250,000,000 4.050%...
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
Amgen’s $4 Billion Senior Unsecured Notes Offerings
Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes...
Amgen’s Acquisition of Rodeo Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Amgen Inc on the deal. Amgen Inc (NASDAQ:AMGN) announced its acquisition of Rodeo Therapeutics. Amgen is one of...